Æȷοì
Iakovos Toumazis
Iakovos Toumazis
Assistant Professor, Department of Health Services Research, MD Anderson Cancer Center
mdanderson.orgÀÇ À̸ÞÀÏ È®ÀÎµÊ - ȨÆäÀÌÁö
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force
R Meza, J Jeon, I Toumazis, K Ten Haaf, P Cao, M Bastani, SS Han, ...
Jama 325 (10), 988-997, 2021
2412021
Risk-Based lung cancer screening: A systematic review
I Toumazis, M Bastani, SS Han, SK Plevritis
Lung cancer 147, 154-186, 2020
1712020
Routing hazardous materials on time-dependent networks using conditional value-at-risk
I Toumazis, C Kwon
Transportation Research Part C: Emerging Technologies 37, 73-92, 2013
1182013
Cost-effectiveness analysis of lung cancer screening in the United States: a comparative modeling study
SD Criss, P Cao, M Bastani, K Ten Haaf, Y Chen, DF Sheehan, EF Blom, ...
Annals of internal medicine 171 (11), 796-804, 2019
1062019
A comparative modeling analysis of risk-based lung cancer screening strategies
K Ten Haaf, M Bastani, P Cao, J Jeon, I Toumazis, SS Han, SK Plevritis, ...
JNCI: Journal of the National Cancer Institute 112 (5), 466-479, 2020
922020
Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from ¡¦
MC Tammemägi, K Ten Haaf, I Toumazis, CY Kong, SS Han, J Jeon, ...
JAMA network open 2 (3), e190204-e190204, 2019
882019
Worst-case conditional value-at-risk minimization for hazardous materials transportation
I Toumazis, C Kwon
Transportation Science 50 (4), 1174-1187, 2016
592016
Disparities of national lung cancer screening guidelines in the US population
SS Han, E Chow, K Ten Haaf, I Toumazis, P Cao, M Bastani, ...
JNCI: Journal of the National Cancer Institute 112 (11), 1136-1142, 2020
542020
Value-at-risk and conditional value-at-risk minimization for hazardous materials routing
I Toumazis, C Kwon, R Batta
Handbook of OR/MS Models in Hazardous Materials Transportation. 193, 127-154, 2013
482013
Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model
SS Han, SA Erdogan, I Toumazis, A Leung, SK Plevritis
Cancer Causes & Control 28, 947-958, 2017
412017
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening
I Toumazis, K de Nijs, P Cao, M Bastani, V Munshi, K Ten Haaf, J Jeon, ...
JAMA oncology, 2021
402021
Handbook of OR/MS models in hazardous materials transportation
R Batta, C Kwon
Springer, 2013
352013
Cost-effectiveness analysis of lung cancer screening accounting for the effect of indeterminate findings
I Toumazis, EB Tsai, SA Erdogan, SS Han, W Wan, A Leung, SK Plevritis
JNCI cancer spectrum 3 (3), pkz035, 2019
312019
Risk model–based lung cancer screening: a cost-effectiveness analysis
I Toumazis, P Cao, K de Nijs, M Bastani, V Munshi, M Hemmati, ...
Annals of internal medicine 176 (3), 320-332, 2023
162023
Evaluation of the Benefits and Harms of Lung Cancer Screening with Low-Dose Computed Tomography: a Collaborative Modeling Study for the US Preventive Services Task Force. 2020
R Meza, J Jeon, I Toumazis, K Ten Haaf, P Cao, M Bastani
Agency for Healthcare Research and Quality, 2020
152020
A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a diagnostic biomarker
I Toumazis, SA Erdogan, M Bastani, A Leung, SK Plevritis
JNCI Cancer Spectrum 5 (6), pkab081, 2021
112021
A risk‐based framework for assessing real‐time lung cancer screening eligibility that incorporates life expectancy and past screening findings
I Toumazis, O Alagoz, A Leung, SK Plevritis
Cancer 127 (23), 4432-4446, 2021
102021
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer
RF Harrison, SB Cantor, CC Sun, M Villanueva, SN Westin, ND Fleming, ...
Gynecologic oncology 161 (1), 56-62, 2021
72021
Comparative effectiveness of up to three lines of chemotherapy treatment plans for metastatic colorectal cancer
I Toumazis, M Kurt, A Toumazi, LG Karacosta, C Kwon
MDM Policy & Practice 2 (2), 2381468317729650, 2017
52017
Prevalence of lung cancer screening among eligible adults in 4 US states in 2021
KG Maki, NQP Tan, I Toumazis, RJ Volk
JAMA Network Open 6 (6), e2319172-e2319172, 2023
42023
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20